Mostra i principali dati dell'item

dc.creatorLialiaris, T. S.en
dc.creatorKouskoukis, A.en
dc.creatorGeorgiou, G.en
dc.creatorTripsianis, G.en
dc.creatorFiska, A.en
dc.creatorGiatromanolaki, A.en
dc.creatorChrisafi, S.en
dc.creatorSivridis, E.en
dc.creatorVamvakopoulou, D. N.en
dc.creatorSoutopoulou, D. O.en
dc.creatorKiritsaka, A.en
dc.creatorAthanassiou, E.en
dc.creatorLialios, G. A.en
dc.creatorSotiriou, S.en
dc.creatorSidiropoulos, A.en
dc.creatorVamvakopoulos, N. C.en
dc.date.accessioned2015-11-23T10:37:51Z
dc.date.available2015-11-23T10:37:51Z
dc.date.issued2011
dc.identifier10.1097/PAI.0b013e3181e181b1
dc.identifier.issn1062-3345
dc.identifier.urihttp://hdl.handle.net/11615/30313
dc.description.abstractExpression of estrogen (ER) and progesterone receptors, c-erbB-2 oncogene, mutant p53 antioncogene (mp53), e-cadherin adhesion, and apoptotic caspase-8 antigens in tumor relative to matched normal tissue specimens from 102 unselected patients with primary ductal breast carcinoma of various tumor grades was assessed by immunohistochemistry and correlated with patient's biologic and clinical features, such as age, menstrual status, age of menarche, tumor grade and diameter, the presence or absence of metastases, and number of infiltrated lymph nodes. We observed association of e-cadherin adhesion, ER and progesterone antigen marker expression with low histologic grade tumors and limited number of lymph node metastases and of c-erbB-2, mp53, and casp-8 antigen marker expression with high histologic grade tumors and increased number of lymph node metastases. We also observed strong correlation (P < 0.05) between 4 of the 6 biomarkers and 4 of the 7 patient/tumor parameters examined. Our findings support the hypothesis of independent expression of these 4 strong biomarkers and reveal that nearly 40% of all breast tumor cases studied express similar proportions of 2 major phenotypic combinations [ER/c-erbB-2/mp53/casp-8: +/+/-/+ (19.6%) & +/-/-/+ (17.8%)]. We conclude that, in agreement with earlier reports, our findings support the diagnostic and potential prognostic value of these markers in the clinical assessment of breast cancer.en
dc.source.uri<Go to ISI>://WOS:000287190000004
dc.subjectbreast canceren
dc.subjectimmunohistochemical markersen
dc.subjectmorphological featuresen
dc.subjectPOSTMENOPAUSAL WOMENen
dc.subjectCANCERen
dc.subjectTHERAPYen
dc.subjectRISKen
dc.subjectP53en
dc.subjectCADHERINSen
dc.subjectESTROGENen
dc.subjectAnatomy & Morphologyen
dc.subjectMedical Laboratory Technologyen
dc.subjectPathologyen
dc.titleExpression of 6 Common Antigenic Markers in Invasive Ductal Breast Carcinoma: Potential Clinical Implicationsen
dc.typejournalArticleen


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item